Immunohistochemistry (CD68-, CD10-, and Factor XIIIa-positive; CD34-negative) distinguished dermatofibroma from dermatofibrosarcoma protuberans, which shows deeper infiltration and CD34 positivity [15,29,30]. The gene discussed is MME; the disease is dermatofibrosarcoma protuberans.